Drug Shortage Report for ACT CLARITHROMYCIN XL
Report ID | 102945 |
Drug Identification Number | 02403196 |
Brand name | ACT CLARITHROMYCIN XL |
Common or Proper name | CLARITHROMYCIN FC TABLETS 500MG |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CLARITHROMYCIN |
Strength(s) | 500MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 60 |
ATC code | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2020-05-15 |
Estimated end date | 2020-06-30 |
Actual end date | 2020-05-27 |
Shortage status | Resolved |
Updated date | 2020-05-29 |
Company comments | Allocating to 100% of our market. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2020-05-29 | French | Compare |
v12 | 2020-05-29 | English | Compare |
v11 | 2020-05-21 | French | Compare |
v10 | 2020-05-21 | English | Compare |
v9 | 2020-05-16 | English | Compare |
v8 | 2020-05-08 | French | Compare |
v7 | 2020-05-08 | English | Compare |
v6 | 2020-04-23 | French | Compare |
v5 | 2020-04-23 | English | Compare |
v4 | 2020-02-13 | French | Compare |
v3 | 2020-02-13 | English | Compare |
v2 | 2020-01-09 | French | Compare |
v1 | 2020-01-09 | English | Compare |
Showing 1 to 13 of 13